Further, we identified seven overlapping genes of vitamin D against HCC and COVID-19 using the network pharmacology approach, and the anti-COVID-19/HCC effects of vitamin D may be modulated by these molecules or genes, including HMOX1, MB, TLR4, ALB, TTR, ACTA1 and RBP4. Here, RBP4 is linked to hepatocellular carcinoma.